Non-communicable diseases such as cancer and cardiovascular disorders kill millions of people each year, with numbers increasing particularly in low- and middle-income countries. The IAEA has ...

Takeda has said it intends to move quickly ahead with regulatory filings for oveporexton, its orexin agonist for sleep disorder narcolepsy, after a clean sweep of positive efficacy data in two phase 3 ...

BenevolentAI is embarking on another round of job losses, closing its US office, and shelving its software-as-a-service business to extend its cash reserves into the third quarter of 2025. The new ...

Build the skills, strategy and credibility to lead AI transformation AI is disrupting every sector, but most professionals lack the clarity and confidence to lead it. The LSE AI Leadership Accelerator ...